COMP <GO>

GALT vs CYPH // 10Y YIELD & FRED MACRO BETA

Galectin Therapeutics Inc. (NASDAQ) VS. Cypherpunk Technologies Inc. (NASDAQ) • 15-METRIC TALLY: GALT 1 — CYPH 3

■ METRIC PARITY

LAST: $3.52 (-0.56%) • MKT CAP: $355.8M

macro-sensitivity

—

LAST: $3.31 (+2.16%) • MKT CAP: $356.7M

macro-sensitivity

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GALT VS. CYPH) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	GALT	CYPH	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	—	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	-23.30%	-11.70	CYPH	/roic <GO>
EV/EBITDA & P/E Valuation	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	-6.71%	-12.31%	+5.60	GALT	/fcf-yield <GO>
Operating Margin	—	—	—	TIE	/operating-margins <GO>
Net Profit Margin	—	—	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	—	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	—	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	3/9	3/9	0.00	TIE	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	40.7	51.0	-10.30	CYPH	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	66.3x	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$355.8M	$356.7M	-$924.5K	CYPH	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	GALT REV	CYPH REV	GALT GROSS %	CYPH GROSS %	GALT FCF	CYPH FCF
FY 2025	$0	$0	—	—	-$23.9M	-$43.9M
FY 2024	$0	$0	—	—	-$41.8M	-$60.3M
FY 2023	$0	$0	—	—	-$33.0M	-$43.8M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

GALT // BETA —

CYPH // BETA —